Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Hold your breath: Air pollution plays role in cardiac, metabolic diseases

March 7, 2011 5:33 am | by EurekAlert | News | Comments

(Michigan State University) To explore one of the most critical health/environment intersections -- how the very air we breathe can cause heart disease and diabetes and contribute to the problems of obesity -- Michigan State University has been named a Clean Air Research Center by the...

Michael Petras, Former CEO of GE Lighting, Named CEO of Cleveland-Based Specialty Medical Supplies Leader

March 7, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

CLEVELAND, March 7, 2011 /- HGI Global Holdings, Inc., a leading provider of specialty medical products to chronic disease patients, today announced the appointment of Michael B. Petras, Jr. as Chief Executive Officer, effective March 21. Mr. Petras, 43, joins HGI from GE Lighting, the...

Uroplasty to Present at ROTH Capital Partners 23rd Annual OC Growth Stock Conference

March 7, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, March 7, 2011 /- Uroplasty, Inc. (Nasdaq: UPI ), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, announced today that it will be presenting at the ROTH Capital Partners 23rd Annual OC Growth Stock...

Advertisement

Boston Scientific Announces European Approval and Launch of OMEGAâ„¢ Platinum Chromium Stent System

March 7, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

NATICK, Mass., March 7, 2011 /- Boston Scientific Corporation (NYSE: BSX ) today announced it has received CE Mark for its OMEGA™ Platinum Chromium Bare-Metal Coronary Stent System, the Company's third-generation coronary stenting technology.  It incorporates Boston...

Isis Pharmaceuticals to Present at the Roth 23rd Annual OC Growth Stock Conference

March 7, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., March 7, 2011 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a company overview at Roth's 23rd Annual OC Growth Stock Conference on Monday, March 14, 2011 at 1:00 p.m. PT at the Ritz...

CT Coronary Angiography Radiation Can Be Reduced While Maintaining Image Quality

March 7, 2011 4:32 am | by Diagnostic Imaging | News | Comments

Through carefully calculated adjustments to coronary imaging using dose-reduction techniques, cardiologists have managed to reduce the radiation delivered to patients undergoing coronary angiograms considerably. Plus, it's possible to maintain good image quality throughout, researchers found.

Reducing CT Coronary Angiography Radiation, Maintaining Imaging Quality

March 7, 2011 4:32 am | by Diagnostic Imaging | News | Comments

Through carefully calculated adjustments to coronary imaging using dose-reduction techniques, cardiologists have managed to reduce the radiation delivered to patients undergoing coronary angiograms considerably. Plus, it's possible to maintain good image quality throughout, researchers found

PAREXEL Experts to Present Advanced Approaches to Accelerate Development, Maximize Product Value at DIA EuroMeeting

March 7, 2011 2:34 am | by Bio-Medicine.Org | News | Comments

BOSTON, March 7, 2011 /- Through various presentations to be delivered at the Drug Information Association (DIA) 23rd Annual EuroMeeting, being held March 28-30, 2011 in Geneva, Switzerland, experts from PAREXEL International Corporation (Nasdaq: PRXL ), a leading global biopharmaceutical...

Advertisement

Aerie Pharmaceuticals Completes $30 Million Series B Financing to Fund Further Development of Innovative Glaucoma Product Portfolio

March 7, 2011 2:34 am | by Bio-Medicine.Org | News | Comments

RESEARCH TRIANGLE PARK, N.C., March 7, 2011 /- Aerie Pharmaceuticals, Inc, a biotechnology company focused on the discovery and development of medical innovations in ophthalmology, today announced the closing of a $30 million Series B financing. Clarus Ventures and Sofinnova Ventures...

Samplify Systems Completes Series B Funding

March 7, 2011 2:34 am | by Bio-Medicine.Org | News | Comments

SANTA CLARA, Calif., March 7, 2011 /- Samplify Systems, Inc., a leading provider of technology, semiconductors and sub-systems for medical, industrial, wireless, and scientific markets, has completed its Series B round of funding.  The $11.2M of capital enables the company to fund...

Dehaier Medical Announces Fourth Quarter and Full-Year 2010 Financial Results

March 7, 2011 2:34 am | by Bio-Medicine.Org | News | Comments

BEIJING, March 7, 2011 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM ) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial...

Rehabilitation within a day of knee replacement pays off

March 6, 2011 5:33 pm | by EurekAlert | News | Comments

(SAGE Publications) Starting rehabilitation sooner following knee arthroplasty surgery could pay dividends -- for both patients and hospitals. Commencing physical therapy within 24 hours of surgery can improve pain, range of joint motion and muscle strength as well as cut hospital stays,...

High-Field MRI: Race to the Top?

March 6, 2011 5:33 pm | by Diagnostic Imaging | News | Comments

Last week, exactly 25 years after the first "high-field" (1.5 T) MRI scanner was introduced, radiologists gathered at an ECR 2011 session in Vienna, Austria, to ponder what its chairman called "higher and higher field magnets."

Advertisement

Contrast MRI Best at Finding Liver Trouble - But Timing Matters

March 6, 2011 5:32 pm | by Diagnostic Imaging | News | Comments

For spotting the tiniest metastases inside the liver, MRI with the liver-specific gadolinium-based contrast agent Primovist (gadoxetic acid) was far and away the top choice of surgeons in an eight-country multicenter study. The surgeons were given a chance to use various imaging methods...

Avoid risking children's health during home energy retrofits, renovations, experts urge

March 6, 2011 8:34 am | by EurekAlert | News | Comments

(Canadian Environmental Law Association) Home energy retrofits and renovations help fight climate change and can create healthier homes but greater training and caution during the process are needed to avoid the release of asbestos, volatile organic compounds, IQ-lowering lead dust and...

Cancer surgery society presents top honor to Kimberly Duchossois(2)

March 5, 2011 2:35 pm | by EurekAlert | News | Comments

(University of Chicago Medical Center) At its annual cancer symposium, the Society of Surgical Oncology will present the 43rd annual James Ewing Layman's Award to Kimberly T. Duchossois of Barrington Hills, Ill., for her deep commitment and long-term efforts to improve the quality of...

Urgent: OTC DRUG Nationwide Recall--Important information for patients about IV PREP Antiseptic Wipes

March 5, 2011 12:34 pm | by Bio-Medicine.Org | News | Comments

ST. PETERSBURG, Fla., March 5, 2011 /- Today, Smith & Nephew's Advanced Wound Management division (LSE: SN; NYSE: SNN ) announced a U.S. voluntary nationwide recall of selected lots of IV PREP Antiseptic Wipes (product number 59421200) manufactured for Smith & Nephew by The Triad...

Manufacturer Gets GMP Warning on Sexual Assault, Blood Alcohol Kits

March 4, 2011 1:30 pm | by U.S. Food & Drug Administration | News | Comments

Lynn Peavey, a manufacturer of sexual assault evidence and blood alcohol collection kits, has received a GMP warning for several issues, such as lack of procedures for incoming product inspections and lack of verification activities.

C. Difficile Guidance May Be Difficult to Adopt

March 4, 2011 1:30 pm | by U.S. Food & Drug Administration | News | Comments

U.S. devicemakers may have difficulty obtaining a virus strain that the FDA suggests using to conduct reactivity tests for new products to detect Clostridium difficile infections.

Site-wide License for Ariadne's Pathway Studio Renewed by NCI

March 4, 2011 10:34 am | by Bio-Medicine.Org | News | Comments

ROCKVILLE, Md., March 4, 2011 /- Ariadne , a leader in bioinformatics software and knowledge integration, announced that National Cancer Institute (NCI) has renewed their license for Pathway Studio ® Enterprise system that includes the ResNet® Mammalian database and Ariadne...

Beaumont First in State to Perform Robotic Heart Procedure for Atrial Fibrillation

March 4, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

ROYAL OAK, Mich., March 4, 2011 /- Doctors at Beaumont Hospital, Troy have performed Michigan's first minimally invasive robotic procedure to correct atrial fibrillation, a prevalent and growing heart rhythm disorder. The new robotic maze procedure is an alternative to open-heart surgery....

Sigma-Aldrich to Present at Upcoming Investor Conferences

March 4, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, March 4, 2011 /- Sigma-Aldrich Corporation (Nasdaq: SIAL ) will be presenting at the following investor conferences in March: 31st Annual Cowen and Company Healthcare Conference on Tuesday, March 8, 2011, at the Boston Marriot Copley Place, Boston, MA, presenting at 10:15 AM...

Topamax (topiramate): Label Change - Risk For Development of Cleft Lip and/or Cleft Palate in Newborns

March 4, 2011 7:30 am | by U.S. Food & Drug Administration | News | Comments

Increased risk of oral clefts in infants born to women treated with Topamax (topiramate) during pregnancy.

Pharmaceutical Launch Excellence Services Delivers Market Entry Road Map

March 4, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

CHAPEL HILL, N.C., March 4, 2011 /- The pressure for a new product to succeed at launch has never been greater with organizations across the pharmaceutical sector facing pipeline deficits, patent expirations and increasing development costs. Facing an ever-changing launch landscape,...

ICAP Ocean Tomo Announces Four Patent Sets From Oxford Instruments - Each Represents an Important Advancement in Technology

March 4, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

CHICAGO, March 4, 2011 /- The Oxford Instruments patents will be auctioned off at ICAP Ocean Tomo's Spring 2011 Live IP Auction on March 31, 2011 in New York City. Oxford Instruments has determined that these patents are not strategic for its ongoing business. The lots include: a concept...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading